Drugs / yttrium-90 carbon microspheres
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05957640 | May 2023 → May 2025 | hepatocellular carcinoma | Zhongda Hospital | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05692037 | Dec 2022 → Dec 2024 | — | Zhongda Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | yttrium-90 carbon microspheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05692037 ↗ |